Medicine
Phospholine Iodide kit
Phospholine Iodide kit is a prescription medicine containing Echothiophate iodide for ophthalmic solution for ophthalmic use, marketed by Fera Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store under refrigeration (2°C to 8°C). Do not refrigerate. After…
Key facts
- Active ingredient (INN)
- Echothiophate iodide for ophthalmic solution
- Brand
- Phospholine Iodide
- Dosage form
- Kit
- Route
- Ophthalmic
- Packs
- 1 kit
- Marketing authorisation holder
- Fera Pharmaceuticals
- Manufacturer
- Fera Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store under refrigeration (2°C to 8°C). Do not refrigerate. After reconstitution: Store upright at room temperature (approximately 25°C) (68°F to 77° F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 June 2022
- Identifiers
- RxCUI 205739, 310049DailyMed set ID 8afc8951-db76-4f27-8752-7c0d6aa47244NDC 48102-053Application NDA011963
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 carton * 6.25 mL in 1 bottle * 5 mL in 1 bottle | 48102-053-05 | Fera Pharmaceuticals | 1 June 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Echothiophate iodide for ophthalmic solution is a prescription medicine indicated for the reduction of elevated IOP. Accommodative Esotropia Concomitant esotropias with a significant accommodative component. It is available as kits for ophthalmic use. MedsAcross supplies Echothiophate iodide for ophthalmic solution for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Echothiophate iodide for ophthalmic solutionFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Phospholine Iodide prescribing information (Fera Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Phospholine Iodide kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.